The Alphabet-backed short-term accommodation portal has internally trimmed its valuation from $31bn amidst Covid-19 restrictions as it fields investor interest.

Posco Capital was among the participants as Cytovant, an Asia-focused spinoff from Roivant Sciences, secured $23.5m a year after it was launched.

The customer service chatbot provider closed a $17.6m round led by Huaxi Holdings subsidiary V-Capital.

Seegrid, which counts Giant Eagle as its largest investor, has received funding from venture firm G2VP at a nine-figure valuation.

Ford Motor and KT both contributed to a series A round that increased the total raised by the driver assistance technology developer to $27m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Perceptive Advisors led a $55m round for Ionis-backed rare disease drug developer Dynacure following a 2018 round that was the same size.

Corporate venturing unit Amgen Ventures contributed to a $25.5m funding round for the microfluidics healthcare technology developer.

Cowen and European Investment Bank added $52m to a $130m first tranche closed by the AbbVie and Pfizer-backed kidney injury drug developer in July.

The WuXi-backed investment firm returned for a series B2 round that will support phase 1/2 trials for iTeos Therapeutics' oncology therapies.